Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Items 201–300 of 1,001
Obligatory role for GPER in cardiovascular aging and disease
Meyer, M. R., Fredette, N. C., Daniel, C., Sharma, G., Amann, K., Arterburn, J. B., Barton, M., & Prossnitz, E. R. (2016) · Science Signaling · doi:10.1126/scisignal.aag0240 · Cited by 87
Balaji, S., Wang, X., King, A., Le, L. D., Bhattacharya, S. S., Moles, C. M., Butte, M. J., Pérez, V. D. J., Liechty, K. W., Wight, T. N., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600856r · Cited by 82
Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis
Chen, H. H., Waghorn, P. A., Wei, L., Tapias, L. F., Schühle, D. T., Rotile, N. J., Jones, C. M., Looby, R. J., Zhao, G., Elliott, J. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91506 · Cited by 79
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Barchetta, I., Cimini, F. A., Ciccarelli, G., Baroni, M. G., & Cavallo, M. G. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01052-3 · Cited by 77
“Fibrosis, the excessive accumulation of extracellular matrix (ECM) components, is the pathological result of severe or repetitive tissue injury [128, 129].”
BackgroundImaging and targeting LOX-mediated tissue remodeling with a reactive collagen peptide
Aronoff, M. R., Hiebert, P., Hentzen, N. B., Werner, S., & Wennemers, H. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00830-6 · Cited by 87
Arunsan, P., Ittiprasert, W., Smout, M. J., Cochran, C. J., Mann, V. H., Chaiyadet, S., Karinshak, S. E., Sripa, B., Young, N. D., Sotillo, J., et al. (2019) · eLife · doi:10.7554/elife.41463 · Cited by 83
Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood
Lewandowski, A. J., Raman, B., Bertagnolli, M., Mohamed, A. B., Williamson, W., Pelado, J. L., McCance, A., Lapidaire, W., Neubauer, S., & Leeson, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.053 · Cited by 77
Bollong, M. J., Yang, B., Vergani, N., Beyer, B. A., Chin, E. N., Zambaldo, C., Wang, D., Chatterjee, A. K., Lairson, L. L., & Schultz, P. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702750114 · Cited by 82
Fiber density modulates cell spreading in 3D interstitial matrix mimetics
Matera, D. L., Wang, W. Y., Smith, M. R., Shikanov, A., & Baker, B. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00141 · Cited by 75
WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling
Chen, H., Moreno‐Moral, A., Pesce, F., Devapragash, N., Mancini, M., Heng, E. L., Rotival, M., Srivastava, P. K., Harmston, N., Shkura, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11551-9 · Cited by 95
Cottin, V. (2019) · European Respiratory Review · doi:10.1183/16000617.0109-2019 · Cited by 86
Discovery of a new class of integrin antibodies for fibrosis
Zhang, J., Wang, T., Saigal, A., Johnson, J., Morrisson, J., Tabrizifard, S., Hollingsworth, S. A., Eddins, M. J., Mao, W., O’Neill, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81253-0 · Cited by 78
Involvement of epithelial-mesenchymal transition in liver fibrosis
Li, N., Yu, K., Li, Q., & Shi, G. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_297_17 · Cited by 80
Li, Z., Yu, S., Hu, X., Li, Y., You, X., Tian, D., Cheng, L., Zheng, M., & Jing, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.720938 · Cited by 85
Dual genetic tracing reveals a unique fibroblast subpopulation modulating cardiac fibrosis
Han, M., Liu, Z., Liu, L., Huang, X., Wang, H., Pu, W., Wang, E., Liu, X., Li, Y., He, L., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01337-7 · Cited by 80
Miyachi, Y., Tsuchiya, K., Komiya, C., Shiba, K., Shimazu, N., Yamaguchi, S., Deushi, M., Osaka, M., Inoue, K., Sato, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.039 · Cited by 73
Fatty acid synthase is required for profibrotic TGF‐β signaling
Jung, M., Kang, J. H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., González-Guerrico, A. M., LIMPER, A. H., & Leof, E. B. (2018) · The FASEB Journal · doi:10.1096/fj.201701187r · Cited by 78
Lee, M.-O., Jung, K. B., Jo, S.-J., Hyun, S.-A., Moon, K.-S., Seo, J.-W., Kim, S.-H., & Son, M.-Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0139-6 · Cited by 72
“These myofibroblasts have high fibrotic activity marked by the expression of α-smooth muscle actin (α-SMA), resulting in myocardial fibrosis and stiffening, which eventually impairs cardiac function [6, 7].”
BackgroundBaranyi, U., Winter, B., Gugerell, A., Hegedűs, B., Brostjan, C., Laufer, G., & Meßner, B. (2019) · Cells · doi:10.3390/cells8070721 · Cited by 83
Late Soft Tissue Complications of Head and Neck Cancer Therapy: Lymphedema and Fibrosis
Deng, J. F., Wulff-Burchfield, E. M., & Murphy, B. A. (2019) · JNCI Monographs · doi:10.1093/jncimonographs/lgz005 · Cited by 78
S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy
Tammaro, A., Florquin, S., den Brok, M. G. H. E., Claessen, N., Butter, L. M., Teske, G. J. D., de Boer, O. J., Vogl, T., Leemans, J. C., & Dessing, M. C. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13154 · Cited by 75
Leung, R. K., Lin, Y., & Liu, Y. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00343-y · Cited by 79
Naringenin: A Promising Therapeutic Agent against Organ Fibrosis
Du, Y., Ma, J., Fan, Y., Wang, X., Zheng, S., Feng, J., Li, J., Fan, Z., Li, G., & Ye, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1210675 · Cited by 72
Anti-fibrotic Potential of AT2 Receptor Agonists
Wang, Y., Del Borgo, M., Lee, H. W., Baraldi, D., Hirmiz, B., Gaspari, T. A., Denton, K. M., Aguilar, M.-I., Samuel, C. S., & Widdop, R. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00564 · Cited by 71
α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis
Zhao, W., Wang, X., Sun, K.-H., & Zhou, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191031 · Cited by 85
A Synthetic Receptor as a Specific Antidote for Paraquat Poisoning
Zhang, X., Xu, X., Li, S., Li, L., Zhang, J., & Wang, R. (2019) · Theranostics · doi:10.7150/thno.31485 · Cited by 73
Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis
Wang, J., Chen, L., Chen, B., Meliton, A., Liu, S. Q., Shi, Y., Liu, T., Deb, D. K., Solway, J., & Chun Li, Y. (2015) · Scientific Reports · doi:10.1038/srep15561 · Cited by 70
Role of mitochondria in pathogenesis and therapy of renal fibrosis
Zhao, X., Li, Y., Yu, J., Teng, H., Wu, S., Wang, Y., Zhou, H., & Li, F. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155913 · Cited by 76
Endoplasmic reticulum stress and kidney dysfunction
Gallazzini, M., & Pallet, N. (2018) · Biology of the Cell · doi:10.1111/boc.201800019 · Cited by 74
Dolivo, D. M., Larson, S. A., & Dominko, T. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.08.013 · Cited by 69
“As various tissue-specific diseases result in fibrotic outcomes, this suggests that common cellular and molecular mechanisms, at least in part, underlie tissue fibrosis across various organs [1].”
BackgroundMitochondrial Pathophysiology on Chronic Kidney Disease
Braga, P. C., Alves, M. G., Rodrigues, A. S., & Oliveira, P. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031776 · Cited by 77
Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
Lin, D.-W., Hsu, Y., Chang, C., Hsieh, C., & Lin, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076053 · Cited by 78
Macrophage-derived MMP12 promotes fibrosis through sustained damage to endothelial cells
Zhou, X., Zhang, C., Yang, S., Yang, L., Luo, W. F., Zhang, W., Zhang, X., & Chao, J. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132733 · Cited by 75
Zhai, M., Liu, Z., Zhang, B., Jing, L., Li, B., Li, K., Chen, X., Zhang, M., Yu, B., Ren, K., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12433 · Cited by 73
Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals
Morrison, R. J., Katsantonis, N., Motz, K., Hillel, A. T., Garrett, C. G., Netterville, J. L., Wootten, C. T., Majka, S. M., Blackwell, T. S., Drake, W. P., et al. (2018) · Otolaryngology · doi:10.1177/0194599818803584 · Cited by 70
Rockey, D. C., Du, Q., & Shi, Z. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.019 · Cited by 83
Self-citationSelf-eating: friend or foe? The emerging role of autophagy in fibrotic diseases
Li, Y., Liu, R., Wu, J., & Li, X. (2020) · Theranostics · doi:10.7150/thno.47826 · Cited by 72
Sárközy, M., Varga, Z., Gáspár, R., Szűcs, G., Kovács, M. G., Kovács, Z. Z. A., László, A., Kahán, Z., & Csont, T. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01809-y · Cited by 82
Li, G., Ren, J., Hu, Q., Deng, Y., Chen, G., Guo, K., Li, R., Li, Y., Wu, L., Wang, G., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.002 · Cited by 69
Andersen, M., Sajid, Z., Pedersen, R. K., Gudmand‐Hoeyer, J., Ellervik, C., Skov, V., Kjær, L., Pallisgaard, N., Kruse, T. A., Thomassen, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183620 · Cited by 75
The mechanisms and potential of stem cell therapy for penile fibrosis
Milenković, U., Albersen, M., & Castiglione, F. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0109-7 · Cited by 74
Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis
Swamy, S., Rajasekaran, N. S., & Thannickal, V. J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.022 · Cited by 69
Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine‐Based Probe
Waghorn, P. A., Jones, C. M., Rotile, N. J., Koerner, S. K., Ferreira, D. S., Chen, H. H., Probst, C. K., Tager, A. M., & Caravan, P. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704773 · Cited by 72
Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells
Bhargava, R., Li, H., & Tsokos, G. C. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000887 · Cited by 69
Zhang, H., Ma, Y., Cheng, X., Wu, D., Huang, X., Chen, B., Ren, Y., Jiang, W., Tang, X., Bai, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd1206 · Cited by 65
Juillerat‐Jeanneret, L., Tafelmeyer, P., & Golshayan, D. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1370455 · Cited by 71
A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease
Patel, D. P., Christensen, M. B., Hotaling, J. M., & Pastuszak, A. W. (2020) · World Journal of Urology · doi:10.1007/s00345-019-02815-6 · Cited by 64
Atrial Myopathy Underlying Atrial Fibrillation
Rivner, H., Mitrani, R. D., & Goldberger, J. J. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.13 · Cited by 70
The NLRP3 inflammasome in fibrosis and aging: The known unknowns
Liu, Y., Xu, X., Lei, W., Hou, Y., Zhang, Y., Tang, R., Yang, Z. P., Tian, Y., Zhu, Y., Wang, C., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101638 · Cited by 66
Ferulic acid: extraction, estimation, bioactivity and applications for human health and food
Kumar, M., Kaushik, D., Shubham, S., Kumar, A., Kumar, V., Öz, E., Brennan, C. S., Zeng, M., Proestos, C., Çadırcı, K., et al. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13931 · Cited by 76
He, S., Li, X., He, Y., Guo, L., Dong, Y., Wang, L., Yang, L., Li, L., Huang, S., Fu, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56223-z · Cited by 78
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
Shearer, A. M., Rana, R., Austin, K. M., Baleja, J., Nguyen, N., Bohm, A., Covic, L., & Kuliopulos, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732743 · Cited by 66
Myofibroblasts and inflammatory cells as players of cardiac fibrosis
Kurose, H., & Mangmool, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0809-6 · Cited by 68
Overstreet, J. M., Wang, Y., Wang, X., Niu, A., Gewin, L. S., Yao, B., Harris, R. C., & Zhang, M. (2017) · The FASEB Journal · doi:10.1096/fj.201601359rr · Cited by 70
Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics
Brigstock, D. R. (2021) · Cells · doi:10.3390/cells10071596 · Cited by 69
Zhang, S., Wei, C., Wang, Q., Wang, L., Lu, L., & Qi, F. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06646-w · Cited by 65
eIF3a: A new anticancer drug target in the eIF family
Yin, J., Zhang, J., Zhang, W., Zhou, H.-H., & Liu, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.055 · Cited by 74
van de Vlekkert, D., Demmers, J., Nguyen, X.-X., Campos, Y., Machado, E., Annunziata, I., Hu, H., Gomero, E., Qiu, X., Bongiovanni, A., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav3270 · Cited by 62
Wu, B., Liu, J., Li, Y., & Li, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4395 · Cited by 73
Common pathway signature in lung and liver fibrosis
Makarev, E., Izumchenko, E., Aihara, F., Wysocki, P., Zhu, Q., Buzdin, A. A., Sidransky, D., Zhavoronkov, A. A., & Atala, A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1152435 · Cited by 69
The impact of fibrotic diseases on global mortality from 1990 to 2019
Mutsaers, H. A. M., Merrild, C., Nørregaard, R., & Plana‐Ripoll, O. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04690-7 · Cited by 73
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., & Du, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336102 · Cited by 88
Zhubanchaliyev, A., Temirbekuly, A., Kongrtay, K., Wanshura, L. C., & Kunz, J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00462 · Cited by 67
da Silva, B. D. O., Ramos, L. F., & Moraes, K. C. M. (2017) · Cell Biology International · doi:10.1002/cbin.10790 · Cited by 64
A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions
Nymark, P. E. H., Rieswijk, L., Ehrhart, F., Jeliazkova, N., Tsiliki, G., Sarimveis, H., Evelo, C. T., Hongisto, V., Kohonen, P. J., Willighagen, E., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx252 · Cited by 65
Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches
Landolt, L. Z., Spagnoli, G. C., Hertig, A., Brochériou, I., & Marti, H. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa301 · Cited by 63
Mechanotransduction in Skin Inflammation
Shutova, M. S., & Boehncke, W. (2022) · Cells · doi:10.3390/cells11132026 · Cited by 66
Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases
Zhu, J., Wang, S., Yang, D., Xu, W., & Qian, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01921-3 · Cited by 70
Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis
Chu, C., & Quan, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123358 · Cited by 71
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 63
Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
Colletti, M., Galardi, A., Santis, M. D., Guidelli, G. M., Giannatale, A. D., Luigi, L. D., & Antinozzi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184337 · Cited by 66
(2024) · doi:10.1007/s00395-024-01074-w · Cited by 59
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis
Kato, S., Inui, N., Hakamata, A., Suzuki, Y., Enomoto, N., Fujisawa, T., Nakamura, Y., Watanabe, H., & Suda, T. (2018) · Respiratory Research · doi:10.1186/s12931-018-0831-y · Cited by 64
Cui, Y., Zhang, M., Leng, C., Blokzijl, T., Jansen, B. H., Dijkstra, G. D. H., & Faber, K. N. (2020) · Cells · doi:10.3390/cells9030775 · Cited by 66
Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 64
Charan, H. V., Dwivedi, D. K., Khan, S., & Jena, G. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.006 · Cited by 62
Renal Fibrosis in Lupus Nephritis
Sciascia, S., Cozzi, M., Barinotti, A., Radin, M., Cecchi, I., Fenoglio, R., Mancardi, D., Jones, G. W., Rossi, D., & Roccatello, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214317 · Cited by 62
Tissue transglutaminase: a multifunctional and multisite regulator in health and disease
Yao, Z., Fan, Y., Lin, L., Kellems, R. E., & Xia, Y. (2023) · Physiological Reviews · doi:10.1152/physrev.00003.2023 · Cited by 65
Fibrotic phenotype of IgG4-related disease
Lanzillotta, M., Culver, E. L., Sharma, A., Zen, Y., Zhang, W., Stone, J. H., & Della‐Torre, E. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00299-0 · Cited by 66
Cellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics
Froom, Z. S. C. S., Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110203 · Cited by 71
Regenerative Biology of Tendon: Mechanisms for Renewal and Repair
Dyment, N. A., & Galloway, J. L. (2015) · Current Molecular Biology Reports · doi:10.1007/s40610-015-0021-3 · Cited by 64
The utility of magnetic resonance imaging for noninvasive evaluation of diabetic nephropathy
Brown, R. S., Sun, M. R. M., Stillman, I. E., Russell, T. L., Rosas, S. E., & Wei, J. L. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz066 · Cited by 57
Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis
Wang, Y., Wang, Y., You, F., & Xue, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104829 · Cited by 60
Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations
Devane, J., Ott, E. B., Olinger, E. G., Epting, D., Decker, E., Friedrich, A., Bachmann, N., Renschler, G., Eisenberger, T., Briem‐Richter, A., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.03.015 · Cited by 63
Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases
Li, X., Fang, Y., Jiang, D., Liu, Y., Liu, Y., Zhang, S., Guo, J., Qi, C., Zhao, C., Jiang, F., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.031 · Cited by 60
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 71
Zou, R., Nie, C., Pan, S., Wang, B., Hong, X., Xi, S., Bai, J., Yu, M., Liu, J., & Yang, W. P. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.010 · Cited by 56
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis
Zhang, H., Zhou, Y., Wen, D., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021801 · Cited by 57
Recent progress and application of the tetrahedral framework nucleic acid materials on drug delivery
Li, J., Yan, R., Shi, S., & Lin, Y. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2276285 · Cited by 57
Molecular Probes for Imaging Fibrosis and Fibrogenesis
Désogère, P. A., Montesi, S. B., & Caravan, P. D. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801578 · Cited by 59
Jing, H., Wang, S., Wang, Y., Shen, N., & Gao, X.-J. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138686 · Cited by 55
Geng, Y., Li, L., Yan, J., Liu, K., Yang, A., Zhang, L., Shen, Y., Gao, H., Wu, X., Noth, I., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34870-w · Cited by 58
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
Hasselbalch, H. C. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.09.002 · Cited by 62
Ruan, Y., Li, M., Wang, T., Yang, J., Rao, K., Wang, S., Yang, W., Liu, J., & Ye, Z. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.02.164 · Cited by 57
Rubio, G. A., Elliot, S. J., Wikramanayake, T. C., Xia, X., Pereira‐Simon, S., Thaller, S. R., Glinos, G. D., Jozic, I., Hirt, P., Pastar, I., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26418 · Cited by 55
Roehlen, N., Saviano, A., El Saghire, H., Crouchet, E., Nehme, Z., Del Zompo, F., Jühling, F., Oudot, M. A., Durand, S. C., Duong, F. H. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4221 · Cited by 54
Heart Failure in Patients with Chronic Kidney Disease
Xanthopoulos, A. V., Papamichail, A., Briasoulis, Α., Loritis, K., Bourazana, A., Magouliotis, D. E., Sarafidis, P. A., Stefanidis, I., Skoularigis, J. S., & Triposkiadis, F. K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186105 · Cited by 69
Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis
Stribos, E. G. D., Luangmonkong, T., Leliveld, A. M., de Jong, I. J., van Son, W. J., Hillebrands, J., Seelen, M. A., van Goor, H., Olinga, P., & Mutsaers, H. A. M. (2015) · Translational research · doi:10.1016/j.trsl.2015.11.007 · Cited by 58
Tian, W., Fan, Z., Li, J., Hao, C., Li, M., Xu, H., Wu, X., Zhou, B., Zhang, L., Fang, M., et al. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.12.005 · Cited by 59
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.